OBJECTIVE: Blastocystosis has been linked with non-specific symptoms, such as diarrhea, abdominal pain, and distention. In this study, we evaluated the relationship between Blastocystis spp. with urticaria and intestinal symptoms. METHODS: The results of the stool examinations of the patients who were referred to Ege University Medical Faculty Hospital's Medical Parasitology Department Direct Diagnosis Laboratory with gastrointestinal (GIS) and/or dermatologic symptoms between January 2011 and July 2016 were retrospectively scanned. RESULTS: Of the evaluated 37108 stool samples, 2573 (6.93 %) were identified to be positive for Blastocystis spp. The patients with gastrointestinal complaints comprised 68.4% of Blastocystis spp. positive samples (1.761 samples) while 30.1% of patients had dermatologic symptoms (urticaria) (776 samples). Blastocystis spp. density in the non-amplified (without using any stool concentration technique) stool samples of the patients with GIS and dermatological symptoms was as follows: 2.47%, 1.35% rare, 21.73%, 22.17% few, 49.65%, 54.29% medium, 26.27%, and 22.17% dense, respectively. CONCLUSION: 75.92% and 76.46% of the patients with GIS and dermatological complaints had medium to dense parasite densities in their stool samples respectively. This suggests a positive correlation between parasite density and GIS and dermatologic symptomatology.
OBJECTIVE: Blastocystosis has been linked with non-specific symptoms, such as diarrhea, abdominal pain, and distention. In this study, we evaluated the relationship between Blastocystis spp. with urticaria and intestinal symptoms. METHODS: The results of the stool examinations of the patients who were referred to Ege University Medical Faculty Hospital's Medical Parasitology Department Direct Diagnosis Laboratory with gastrointestinal (GIS) and/or dermatologic symptoms between January 2011 and July 2016 were retrospectively scanned. RESULTS: Of the evaluated 37108 stool samples, 2573 (6.93 %) were identified to be positive for Blastocystis spp. The patients with gastrointestinal complaints comprised 68.4% of Blastocystis spp. positive samples (1.761 samples) while 30.1% of patients had dermatologic symptoms (urticaria) (776 samples). Blastocystis spp. density in the non-amplified (without using any stool concentration technique) stool samples of the patients with GIS and dermatological symptoms was as follows: 2.47%, 1.35% rare, 21.73%, 22.17% few, 49.65%, 54.29% medium, 26.27%, and 22.17% dense, respectively. CONCLUSION: 75.92% and 76.46% of the patients with GIS and dermatological complaints had medium to dense parasite densities in their stool samples respectively. This suggests a positive correlation between parasite density and GIS and dermatologic symptomatology.
Authors: Mayra Ximena Robles-Cabrera; Jorge L Maguiña; Luis Gonzales-Huerta; Vicky Panduro-Correa; Bernardo Dámaso-Mata; Samuel Pecho-Silva; Ana Claudia Navarro-Solsol; Ali A Rabaan; Alfonso J Rodríguez-Morales; Kovy Arteaga-Livias Journal: Infect Chemother Date: 2021-06